Microbia (Cambridge, MA) rational drug designer focused on GI and cardiovascular therapeutics raised a $50M series F round. The financing was led by Ridgeback Capital and joined by Morgan Stanley Investment Management.
Microbia, Inc.: Series F $50M
March 6, 2007
Leave a Comment » | 
I - Series F, R - NORTH EAST, X - Cardiology, X - GI | 
Permalink
Posted by arubenstein
